Accéder au contenu
Merck

N-phenylmaleimide derivatives as mimetic agents of the pro-inflammatory process: myeloperoxidase activation.

Pharmacological reports : PR (2011-08-23)
Vânia F Noldin, Silvana V G Vigil, Rafael De Liz, Valdir Cechinel-Filho, Tânia S Fröde, Tânia B Creczynski-Pasa
RÉSUMÉ

Myeloperoxidase (MPO) is an important enzyme that catalyzes the reaction between hydrogen peroxide and chloride to generate hypochlorous acid, which oxidizes a range of biomolecules and has been associated with inflammatory diseases. The synthetic compounds N-phenylmaleimide (NFM) and 4-methyl-N-phenylmaleimide (Me-NFM) increased the MPO activity in vitro (of isolated enzyme and in isolated cells after animal treatment) and in vivo assays. MPO-induction may represent a good model system to investigate the molecular and cellular mechanisms of oxidative cell injury induced by activated neutrophils, and the interactions between damaging species involved in the respiratory burst.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
N-Phenylmaleimide, 97%